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The current practice of treating every 
baby whose mother has been diagnosed 
with chorioamnionitis with a rule out 
sepsis evaluation and antibiotics is not a 
valid practice. Implementation of a sepsis 
calculator can safely decrease the 
number of babies empirically treated with 
antibiotics, reduce the adverse effects of 
antibiotic usage, save money and 
decrease the grief parents experience 
when separated from their newborn after 
delivery.
Is the current practice of treating every baby whose mother has been 
diagnosed with chorioamnionitis with a rule out sepsis evaluation and 
antibiotics a valid practice? 
REFERENCES
• The Kaiser Sepsis calculator provides 
insight for physicians dealing with 
neonates born to a mother diagnosed 
with chorioamnionitis and appears 
valid in our patient population. 
• Reducing the antibiotic usage will save 
the neonates from the potential 
adverse effects of hearing and renal 
issues in neonates
• Support new measures that can safely 
increase bonding between mother and 
child should be supported
• Reduce costs associated with NICU 
stays
Project Relationship to SELECT 
principles
– fewer adverse effects from antibiotics 
– more efficient use of resource
Followup- 5 months post 
implementation to verify appropriateness
This is an internally designated quality 
improvement study. The NICU log book 
was reviewed and every neonate from 
February 7, 2017 until February 26, 2018, 
who was ≥36 weeks and whose mom 
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Problem Statement
 Chorioamnionitis is defined as an 
infection and inflammation of the fetal 
membranes1.
 The current guidelines recommend to 
obtain a blood culture and to treat the 
neonate empirically with gentamycin and 
ampicillin for 48 hours 4
 These antibiotics are not without side 
effects:
 Hearing5 and renal6 disturbances
 Antibiotics require NICU stay
 Decreases parental bonding11, 
breastfeeding12 and is expensive18
 Kaiser Sepsis calculator was created to 
reduce empiric antibiotic usage, It is 
validated in other patient 
populations14,15, will it be valid in ours?
• From February 7, 2017 until February 
26, 2018, 124 neonates were admitted 
to the NICU due to mother’s 
chorioamnionitis status and treated 
empirically with antibiotics. Due to 
recording and EPIC issues, only 116 
neonate’s charts were able to be 
accessed and reviewed on EPIC. 
Is the current practice of treating every 
baby whose mother has been diagnosed 
with chorioamnionitis with a rule out sepsis 
evaluation and antibiotics a valid practice? 
Can implementation of a sepsis calculator 
safely decrease the number of babies 








116 neonates treated 0 positive blood cultures
116
empiric antibiotics, vitals per nicu 2
blood culture, vitals every 4 for 24 hours 22
no culture/antibiotics, vitals every 4 for 24hours 37









Figure 5- number of 
neonates in each 
category based 
upon calculator data
 20.7% (24 out of the 116)-blood cultures
 1.7% (2 out of 116)- empiric antibiotics. 
 198.5mins- average time spent in NICU. 
 0 positive blood cultures.
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